Techne Corporation (TECH): Net earnings per share (EPS TTM)

Bio-Techne Corporation (TECH) - corporate logo

Bio-Techne Corporation (TECH) relies on strict FDA control and patent protection of biocomponents. The strategy is based on partnerships with pharmaceutical behemoths in the field of cell therapy. Leadership in cytokine production creates high switching costs for customers. This 12-month net income per share chart visualizes this success, where the 1.10 mark characterizes this parameter.

Bio-Techne Corporation (TECH) - Earnings per share for the trailing year from 07/04/2022 to 11/12/2026

Analytical breakdowns and data insights for company Bio-Techne Corp (TECH)

- stock price and consensus target price:
Stock Price Bio-Techne Corporation|TECH - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Bio-Techne Corporation|TECH - Real Price to Acquire Entire Company
- business book valuation details:
Accounting Value per Share Bio-Techne|TECH - Accounting Value of Company|Market Value to Book Value Ratio bio-techne.com|TECH - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital Bio-Techne Corporation|TECH - Long-Term Liabilities to Capital|Short-Term Debt to Capital Techne Corporation|TECH - Company Aggregate Debt|Debts to Book Capitalization Bio-Techne Corporation|TECH - Long-Term Debt Volume|Company Short-Term Debts Bio-Techne|Quick Ratio bio-techne.com
- earnings and valuation multiples indicators:
TECH - Net Profit|Expected Profit Bio-Techne Corporation|TECH - Price to Earnings Ratio|Projected Price to Earnings Bio-Techne|TECH - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Bio-Techne Corporation|TECH - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Bio-Techne|TECH - Net earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months bio-techne.com|TECH - Earnings growth in current year|Earnings growth forecast for next year Bio-Techne Corporation
Fundamental valuation:Bio-Techne Corporation (TECH)
Manufactured products of Bio-Techne Corp

The stability of reagent sales for Bio-Techne Corporation (TECH) amid volatile funding for biotech startups converts directly into net profit distributed per common share. This calculation strips the final income of the impact of issuance, allowing the 12-month rolling per-share income metric to assess the real resilience of the business and its ability to generate profit without excessive debt pressure.

Competitors of Bio-Techne Corporation

Abbott Laboratories - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters thermofisher.com TMO|GEHC: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Mettler-Toledo|Net earnings per share for the last 12 months WAT|BRKR: Earnings per share for the trailing year|Earnings per share for the last twelve months Azenta, Inc. (AZTA)|Net earnings per share for the last 12 months vareximaging.com VREX|Net earnings per share (EPS TTM) SMLR (Semler Scientific)|Butterfly Network Inc (BFLY) - Net earnings per one share for the last twelve months|Mesa Labs Corp - Net earnings per share (EPS TTM)|QSI (Quantum-Si Corporation) - Earnings per share for the last 12 months|NNOX: Net earnings per share (EPS TTM)|QTRX - Net earnings per share for the last four quarters|MASS (908 Devices) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months CapsoVision Medical (CV)|Net earnings per share (EPS TTM) MXCT|Net earnings per share (EPS TTM) rapidmicrobio.com (RPID)|Earnings per share for the last twelve months Seer, Inc. SEER|hyperfine.io - Earnings per share for the last twelve months|FONR: Net earnings per share for the last 12 months|Earnings per share for the trailing year DXR (Daxor Corporation)|MDAI: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Organovo Holdings Inc. (VIVS)|Earnings per share for the last twelve months Aclarion|AKYA - Net earnings per share for the trailing year|Net earnings per share for the last 12 months THMO (ThermoGenesis Holdings)|Net earnings per share (EPS TTM) talis.bio (TLIS)|Net earnings per share (EPS TTM) TTOO (T2 Biosystems, Inc)